F
Clovis Oncology, Inc. CLVSQ
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Revenue 133.02M 140.27M 144.95M 148.76M 156.09M
Total Other Revenue -- -- -- -- --
Total Revenue 133.02M 140.27M 144.95M 148.76M 156.09M
Cost of Revenue 31.59M 32.84M 33.26M 33.46M 34.54M
Gross Profit 101.43M 107.44M 111.69M 115.30M 121.55M
SG&A Expenses 125.53M 127.34M 127.67M 128.40M 135.81M
Depreciation & Amortization 5.37M 5.37M 5.37M 5.37M 5.37M
Other Operating Expenses 25.64M 24.35M 14.94M 14.92M 11.43M
Total Operating Expenses 339.41M 356.62M 357.29M 368.75M 388.65M
Operating Income -206.39M -216.34M -212.34M -219.99M -232.56M
Income Before Tax -252.31M -263.73M -258.81M -264.93M -299.64M
Income Tax Expenses -405.00K -427.00K -389.00K -403.00K -549.00K
Earnings from Continuing Operations -251.91 -263.30 -258.42 -264.53 -299.09
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -251.91M -263.30M -258.42M -264.53M -299.09M
EBIT -206.39M -216.34M -212.34M -219.99M -232.56M
EBITDA -198.68M -208.50M -204.16M -211.50M -224.01M
EPS Basic -1.82 -1.99 -2.11 -2.31 -2.83
Normalized Basic EPS -1.13 -1.21 -1.28 -1.40 -1.57
EPS Diluted -1.82 -1.99 -2.11 -2.31 -2.83
Normalized Diluted EPS -1.13 -1.21 -1.28 -1.40 -1.57
Average Basic Shares Outstanding 555.34M 531.93M 496.37M 462.42M 430.63M
Average Diluted Shares Outstanding 555.34M 531.93M 496.37M 462.42M 430.63M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings